A high-energy electromagnetic therapy that penetrates deep into musculoskeletal tissues to reduce pain, accelerate healing, and promote tissue regeneration through electromagnetic transduction.
Extracorporeal Magnetotransduction Therapy (EMTT) is a non-invasive treatment that delivers high-energy electromagnetic pulses at oscillation frequencies of approximately 100-300 kHz. Unlike conventional PEMF (pulsed electromagnetic field) therapy, EMTT generates significantly higher magnetic flux densities that can penetrate deep into bone and soft tissue.
The electromagnetic energy induces electrical fields within target tissues, stimulating cellular repair mechanisms and modulating pain signaling pathways. EMTT is particularly effective for musculoskeletal conditions and is often combined with other treatments such as shockwave therapy.
EMTT generates rapidly oscillating electromagnetic fields that induce transmembrane potential changes in cells within the treatment zone. This triggers several biological responses: activation of growth factor signaling pathways; upregulation of anti-inflammatory cytokines; stimulation of osteoblast and chondrocyte proliferation; and modulation of pain-related nociceptive signaling.
The high penetration depth (up to 18 cm into tissue) makes EMTT effective for deep-seated musculoskeletal conditions that are difficult to reach with surface-level treatments.
EMTT is selected based on the specific musculoskeletal or pain condition. Our specialists will evaluate whether this therapy is appropriate for your situation.
The EMTT applicator is positioned over the treatment area. Sessions last 5-15 minutes per region. The patient may feel a gentle pulling or tingling sensation but the treatment is non-painful. No anesthesia or preparation is required. Most patients receive 4-8 sessions at weekly intervals. EMTT is frequently combined with shockwave therapy for enhanced results in musculoskeletal conditions.
EMTT is a newer technology with a growing evidence base. Published studies demonstrate efficacy for chronic low back pain, knee osteoarthritis, and bone healing. The technology has received CE marking for musculoskeletal applications. EMTT has a favorable safety profile with no reported serious adverse events. It is contraindicated in patients with cardiac pacemakers, pregnancy over the treatment area, and active infections in the target region.
Contact our medical team to discuss whether electromagnetic transduction therapy may help with your musculoskeletal condition.
